These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32779100)

  • 1. Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2).
    Ghosh S; Tiwaskar M; Chawla R; Jaggi S; Asirvatham A; Panikar V
    Diabetes Ther; 2020 Oct; 11(10):2257-2268. PubMed ID: 32779100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study).
    Ghosh S; Trivedi S; Sanyal D; Modi KD; Kharb S
    Diabetes Metab Syndr Obes; 2016; 9():347-353. PubMed ID: 27877058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2).
    Saboo B; Ghosh S; Tiwaskar M; Chawla R
    Diabetes Metab Syndr; 2021; 15(5):102264. PubMed ID: 34488059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on Therapy.
    Kumar A; Prakash AS
    J ASEAN Fed Endocr Soc; 2019; 34(1):87-91. PubMed ID: 33442141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study.
    Agarwal P; Jindal C; Sapakal V
    Indian J Endocrinol Metab; 2018; 22(1):41-46. PubMed ID: 29535935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan.
    Kadowaki T; Inagaki N; Watada H; Sasaki K; Mori-Anai K; Iwasaki T; Teranishi T
    Adv Ther; 2022 Apr; 39(4):1642-1658. PubMed ID: 35138572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus.
    Tandon T; Dubey AK; Srivastava S; Manocha S; Arora E; Hasan N
    J Family Med Prim Care; 2019 Mar; 8(3):955-959. PubMed ID: 31041232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Safety and Efficacy of Teneligliptin at a Higher Dose in Indian Type 2 Diabetes Patients: A Retrospective Analysis.
    Mitra A; Ray S
    Cureus; 2020 Jan; 12(1):e6812. PubMed ID: 32140368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teneligliptin in Early Diabetic Kidney Disease: An Observation in Asian Indian Patients with Type 2 Diabetes Mellitus in Real-Life Scenario.
    Shah K
    J Clin Diagn Res; 2017 Jun; 11(6):OC22-OC25. PubMed ID: 28764219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.
    Kadowaki T; Inagaki N; Kondo K; Nishimura K; Kaneko G; Maruyama N; Nakanishi N; Watanabe Y; Gouda M; Iijima H
    Diabetes Obes Metab; 2018 Jan; 20(1):77-84. PubMed ID: 28608617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li X; Huang X; Bai C; Qin D; Cao S; Mei Q; Ye Y; Wu J
    Front Pharmacol; 2018; 9():449. PubMed ID: 29780322
    [No Abstract]   [Full Text] [Related]  

  • 12. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records.
    Polavarapu NK; Kale R; Sethi B; Sahay RK; Phadke U; Ramakrishnan S; Mane A; Mehta S; Shah S
    Drugs Real World Outcomes; 2020 Dec; 7(4):271-279. PubMed ID: 32648242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indian Expert Review on Use of Teneligliptin in patients with Diabetes and its Safety and Efficacy (INTENSE).
    Chowdhury S; Chadha M; Ghosh S; Majumder A; Sanyal D; Goswami S; Giri D; Baidya A; Sahana PK; Sinha A; Maiti A; Bhattacharjee R; Roy A; Das S
    J Assoc Physicians India; 2021 Jan; 69(1):61-70. PubMed ID: 34227778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes.
    Pelluri R; Kongara S; Nagasubramanian VR; Mahadevan S; Chimakurthy J
    J Endocrinol Invest; 2023 May; 46(5):855-867. PubMed ID: 36624224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study).
    Gupta A
    Curr Diabetes Rev; 2019; 15(6):510-519. PubMed ID: 31713476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Effectiveness and Safety of Lixisenatide as Add-On to Oral Antidiabetic Drugs as Part of Routine Clinical Practice in Bulgaria: LIXODAR Study.
    Temelkova N; Vladeva S; Delchev A; Ivanova K; Gerasimova-Zheleva Y; Kuneva T; Pehlivanova V; Popivanov P
    Diabetes Ther; 2019 Jun; 10(3):981-993. PubMed ID: 30919317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report.
    Kim HJ; Kim YS; Lee CB; Choi MG; Chang HJ; Kim SK; Yu JM; Kim TH; Lee JH; Ahn KJ; Kim K; Lee KW
    Diabetes Ther; 2019 Aug; 10(4):1271-1282. PubMed ID: 31079357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study.
    Kim HJ; Kim YS; Lee CB; Choi MG; Chang HJ; Kim SK; Yu JM; Kim TH; Lee JH; Ahn KJ; Min KW; Kyung EJ; Kim YK; Lee KW
    Diabetes Ther; 2021 Nov; 12(11):2907-2920. PubMed ID: 34536208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin.
    Al Omari M; Khader Y; Dauod AS; Beni Yonis OA; Khassawneh AH
    J Drug Assess; 2016; 5(1):29-33. PubMed ID: 27994943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.